A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Doses of IPI-201 Administered Intravenously in Healthy Male Participants

Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2025
This article has no abstract
Epistemonikos ID: bb6c50aeafd2b469fb89ffd72e5227ab40f5b801
First added on: Nov 03, 2025